Erratum to: Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial

Affiliations

• ¹ National and Kapodistrian University of Athens, Medical School, Athens, Greece. geros@otenet.gr.
• ² Heart Failure Unit, Department of Cardiology, Athens University Hospital Attikon, 1 Rimini St, 12462, Athens, Greece. geros@otenet.gr.
• ³ National and Kapodistrian University of Athens, Medical School, Athens, Greece.
• ⁴ University of Brescia, Brescia, Italy.
• ⁵ Momentum Research Inc., Durham, NC, USA.
• ⁶ Duke Clinical Research Institute, Durham, NC, USA.
• ⁷ University of California at San Diego, San Diego, CA, USA.
• ⁸ Novartis Pharmaceuticals Corporation, New Hanover, NJ, USA.
• ⁹ Indiana University School of Medicine and Regenstrief Institute, Indianapolis, IN, USA.
• ¹⁰ Clinical Military Hospital, Medical University, Wroclaw, Poland.
• ¹¹ Columbia University, New York, NY, USA.
• ¹² Novartis Pharma AG, Basel, Switzerland.
• ¹³ University of Groningen, Groningen, The Netherlands.
• ¹⁴ University of California-San Francisco and San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA.